MedPath

A multi-institutional clinical trial of proton beam therapy for localized intermediate-risk prostate cancer

Not Applicable
Recruiting
Conditions
localized intermediate-risk prostate cancer
Registration Number
JPRN-UMIN000025453
Lead Sponsor
niversity of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Previous prostate cancer treatment: surgery, HIFU, chemotherapy, and others Other cancers within 5 years History of radiation therapy for pelvis Uncontrolled infection or DM more than 135 Kg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5-year biochemical relapse-free survival rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath